The Invus Group

PE / buyout · New York, New York

Founded in 1985, The Invus Group is a private equity firm based in New York. 47 portfolio companies are on record.

AUM
$10.0B
Portfolio companies
47
Recorded deals
1
Last investment
—

The Invus Group key facts

  • The Invus Group is a private equity firm based in New York, New York with 47 tracked portfolio companies.
  • Notable positions include Kailera Therapeutics (NAS: KLRA), Mirador Therapeutics, Parabilis Medicines.
  • The team roster lists 59 people.

About The Invus Group

Founded in 1985, The Invus Group is a private equity firm based in New York. The firm prefers to invest in consumer products and services, food, technology, life science, software, agtech, industrial, education, and medical devices sectors.

The Invus Group portfolio at a glance

47 portfolio companies are on record for The Invus Group, including Kailera Therapeutics (NAS: KLRA), Mirador Therapeutics and Parabilis Medicines.

35 of the 47 carry a recorded valuation.

The Invus Group team

59 people are on record at The Invus Group: 18 associates, 17 partners, 11 managing partners, 2 principals and 11 others. Senior names include Aflalo Guimarães (Managing Director), Benedetto Staccia (Managing Director) and Christopher Sobecki (Managing Director). 58 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 47 recorded positions
  • ·Watchlist + alerts for The Invus Group's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

47 companies · priced for members
CompanyValuationRole
Kailera Therapeutics (NAS: KLRA)▮▮
Mirador Therapeutics▮▮
Parabilis Medicines▮▮
+ 44 more companies · all 47, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Team
59 people on record — 58 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about The Invus Group

What companies does The Invus Group invest in?
The Invus Group has 47 recorded portfolio companies, including Kailera Therapeutics (NAS: KLRA), Mirador Therapeutics, Parabilis Medicines.
What is The Invus Group's AUM?
The Invus Group manages approximately $10.0B in assets.